Skip to main content Accessibility help
×
Hostname: page-component-6d856f89d9-8l2sj Total loading time: 0 Render date: 2024-07-16T06:45:41.836Z Has data issue: false hasContentIssue false

66 - Plague

from Part IV - Current Topics

Published online by Cambridge University Press:  15 December 2009

David M. Stier
Affiliation:
Medical Epidemiologist, Medical Director, Adult Immunization and Travel Clinic, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
Nikkita Patel
Affiliation:
Research Assistant, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
Olivia Bruch
Affiliation:
Health Program Coordinator, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
Karen A. Holbrook
Affiliation:
Medical Epidemiologist, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
Rachel L. Chin
Affiliation:
University of California, San Francisco
Get access

Summary

INTRODUCTION

Plague is an acute bacterial infection caused by Yersinia pestis, a member of the family Enterobacteriaceae. Y. pestis is a pleomorphic, nonmotile, nonsporulating, intracellular, gram-negative bacillus that has a characteristic bipolar appearance on Wright, Giemsa, and Wayson's stains. There are three virulent biovars – antiqua, mediaevalis, and orientalis – and a fourth avirulent biovar, microtus. The orientalis biovar is thought to have originated in southern China and caused the most recent pandemic.

The Working Group for Civilian Biodefense considers plague to be a potential biological weapon because of the pathogen's availability “around the world, its capacity for its mass production and aerosol dissemination, and the difficulty in preventing such activities, high fatality rate of pneumonic plague, and potential for secondary spread of cases during an epidemic.” Of the potential ways in which Y. pestis could be used as a biological weapon, aerosol release would be most likely. This method has been successfully demonstrated to cause disease in Rhesus macaques.

EPIDEMIOLOGY

Plague as a Biological Weapon

In the 20th century, countries including the United States, the former Soviet Union, and Japan developed ways for using Y. pestis as a weapon. Creating aerosolized plague is technically challenging; however, if an intentional release of aerosolized plague were to take place, an outbreak of pneumonic plague would be likely. This would be of serious concern because of the high case-fatality rate and the potential for person-to-person transmission.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Begier, E M, Asiki, G, Anywaine, Z, et al. Pneumonic plague cluster, Uganda, 2004. Emerg Infect Dis 2006;12(3):460–7.CrossRefGoogle Scholar
Bin Saeed, A A, Al-Hamdan, N A, Fontaine, R E. Plague from eating raw camel liver. Emerg Infect Dis 2005;11(9):1456–7.CrossRefGoogle ScholarPubMed
Brouillard, J E, Terriff, C M, Tofan, A, et al. Antibiotic selection and resistance issues with fluoroquinolones and doxycycline against bioterrorism agents. Pharmacotherapy 2006;26(1):3–14.CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention (CDC). Human plague – four states, 2006. MMWR 2006;55(34):940–3.
Cono, J, Cragan, J D, Jamieson, D J, et al. Prophylaxis and treatment of pregnant women for emerging infections and bioterrorism emergencies. Emerg Infect Dis 2006;12(11):1631–7.CrossRefGoogle ScholarPubMed
Drancourt, M, Houhamdi, L, Raoult, D. Yersinia pestis as a telluric, human ectoparasite-borne organism. Lancet Infect Dis 2006;6(4):234–41.CrossRefGoogle ScholarPubMed
Elvin, S J, Eyles, J E, Howard, K A, et al. Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine. Vaccine 2006;24(20):4433–9.CrossRefGoogle ScholarPubMed
Franz, D R, Jahrling, P B, Friedlander, A M, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997;278(5):399–411.CrossRefGoogle ScholarPubMed
Galimand, M, Carniel, E, Courvalin, P. Resistance of Yersinia pestis to antimicrobial agents. Antimicrob Agents Chemother 2006;50(10):3233–6.CrossRefGoogle ScholarPubMed
Koirala, J. Plague: disease, management, and recognition of act of terrorism. Infect Dis Clin North Am 2006;20(2):273–87, viii.CrossRefGoogle ScholarPubMed
Kool, J L. Risk of person-to-person transmission of pneumonic plague. Clin Infect Dis 2005;40(8):1166–72.CrossRefGoogle ScholarPubMed
Mwengee, W, Butler, T, Mgema, S, et al. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania. Clin Infect Dis 2006;42(5):614–21.CrossRefGoogle ScholarPubMed
Rose, L J, Donlan, R, Banerjee, S N, et al., Survival of Yersinia pestis on environmental surfaces. Appl Environ Microbiol 2003;69(4):2166–71.CrossRefGoogle ScholarPubMed
Borio L L. Plague as an agent of bioterrorism. In: Mandell, G L, Bennett, J E, Dolin, R, eds, Principles and practice of infectious diseases (6th ed). New York: Churchill Livingstone, 2005.Google Scholar
Butler T, Dennis D T. Yersinia species including plague. In: Mandell, G L, Bennett, J E, Dolin, R, eds, Principles and practice of infectious diseases (6th ed). New York: Churchill Livingstone, 2005.Google Scholar
Center for Infectious Disease Research and Policy (CIDRAP). Plague: current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, treatment, and prophylaxis. Retrieved March 5, 2007, from http://www.cidrap.umn.edu/cidrap/content/bt/plague.
Inglesby, T V, Dennis, D T, Henderson, D A, et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 2000;283(17):2281–90.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Plague
    • By David M. Stier, Medical Epidemiologist, Medical Director, Adult Immunization and Travel Clinic, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Nikkita Patel, Research Assistant, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Olivia Bruch, Health Program Coordinator, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Karen A. Holbrook, Medical Epidemiologist, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
  • Edited by Rachel L. Chin, University of California, San Francisco
  • Book: Emergency Management of Infectious Diseases
  • Online publication: 15 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547454.067
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Plague
    • By David M. Stier, Medical Epidemiologist, Medical Director, Adult Immunization and Travel Clinic, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Nikkita Patel, Research Assistant, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Olivia Bruch, Health Program Coordinator, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Karen A. Holbrook, Medical Epidemiologist, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
  • Edited by Rachel L. Chin, University of California, San Francisco
  • Book: Emergency Management of Infectious Diseases
  • Online publication: 15 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547454.067
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Plague
    • By David M. Stier, Medical Epidemiologist, Medical Director, Adult Immunization and Travel Clinic, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Nikkita Patel, Research Assistant, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Olivia Bruch, Health Program Coordinator, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Karen A. Holbrook, Medical Epidemiologist, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
  • Edited by Rachel L. Chin, University of California, San Francisco
  • Book: Emergency Management of Infectious Diseases
  • Online publication: 15 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547454.067
Available formats
×